Establishment of inducible CRISPR/Cas9 system in human AML cell lines

BH Bai‐Liang He
NY Ning Yang
CM Cheuk Him Man
NN Nelson Ka‐Lam Ng
CC Chae‐Yin Cher
HL Ho‐Ching Leung
LK Leo Lai‐Hok Kan
BC Bowie Yik‐Ling Cheng
SL Stephen Sze‐Yuen Lam
MW Michelle Lu‐Lu Wang
CZ Chun‐Xiao Zhang
HK Hin Kwok
GC Grace Cheng
RS Rakesh Sharma
AM Alvin Chun‐Hang Ma
CS Chi‐Wai Eric So
YK Yok‐Lam Kwong
AL Anskar Yu‐Hung Leung
request Request a Protocol
ask Ask a question
Favorite

MOLM‐13 cell line was infected by pCW‐Cas9, doxycycline‐inducible lentiviral expressing Cas9 (Addgene plasmid #50661), and positively infected cells were selected by 2 μg/ml puromycin. sgRNAs (Table EV4) targeting p90RSK and CREB were cloned into pLKO5.sgRNA.EFS.tRFP657 (Addgene plasmid #57824). sgRNA lentivirus was prepared and used to infect inducible Cas9‐expressing human AML cell lines. Positive sgRNA‐infected cells were sorted based on tRFP657 expression. Cas9 was induced by 2 μg/ml doxycycline, and the cells were harvested 2 days after induction and subjected to subsequent analyses.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A